106 related articles for article (PubMed ID: 18992151)
1. Methylation of WTH3, a possible drug resistant gene, inhibits p53 regulated expression.
Tian K; Wang Y; Huang Y; Sun B; Li Y; Xu H
BMC Cancer; 2008 Nov; 8():327. PubMed ID: 18992151
[TBL] [Abstract][Full Text] [Related]
2. WTH3, which encodes a small G protein, is differentially regulated in multidrug-resistant and sensitive MCF7 cells.
Tian K; Jurukovski V; Yuan L; Shan J; Xu H
Cancer Res; 2005 Aug; 65(16):7421-8. PubMed ID: 16103095
[TBL] [Abstract][Full Text] [Related]
3. WTH3 is a direct target of the p53 protein.
Tian K; Wang Y; Xu H
Br J Cancer; 2007 May; 96(10):1579-86. PubMed ID: 17426708
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of WTH3 in primary and cultured drug-resistant breast cancer cells.
Tian K; Jurukovski V; Wang XP; Kaplan MH; Xu H
Cancer Res; 2005 Nov; 65(21):10024-31. PubMed ID: 16267028
[TBL] [Abstract][Full Text] [Related]
5. WTH3, a new member of the Rab6 gene family, and multidrug resistance.
Shan J; Yuan L; Budman DR; Xu HP
Biochim Biophys Acta; 2002 Apr; 1589(2):112-23. PubMed ID: 12007787
[TBL] [Abstract][Full Text] [Related]
6. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
7. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis P; El-Osta A; deSilva M; Wall DM; Hu XF; Slater A; Nadalin G; Parkin JD; Zalcberg JR
Clin Cancer Res; 1997 Nov; 3(11):2025-32. PubMed ID: 9815593
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.
Hodge DR; Peng B; Cherry JC; Hurt EM; Fox SD; Kelley JA; Munroe DJ; Farrar WL
Cancer Res; 2005 Jun; 65(11):4673-82. PubMed ID: 15930285
[TBL] [Abstract][Full Text] [Related]
10. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
Hua J; Mutch DG; Herzog TJ
Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells.
Jin W; Scotto KW; Hait WN; Yang JM
Biochem Pharmacol; 2007 Sep; 74(6):851-9. PubMed ID: 17662696
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
13. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
Han CY; Cho KB; Choi HS; Han HK; Kang KW
Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
[TBL] [Abstract][Full Text] [Related]
14. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs.
Baker EK; Johnstone RW; Zalcberg JR; El-Osta A
Oncogene; 2005 Dec; 24(54):8061-75. PubMed ID: 16091741
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells.
Kim KJ; Moon SM; Kim SA; Kang KW; Yoon JH; Ahn SG
Oncogene; 2013 Jul; 32(28):3339-49. PubMed ID: 22907429
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
Dönmez Y; Gündüz U
Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
[TBL] [Abstract][Full Text] [Related]
19. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
Yu ST; Chen TM; Tseng SY; Chen YH
Biochem Biophys Res Commun; 2007 Jun; 358(1):79-84. PubMed ID: 17482571
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
